These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19595768)

  • 1. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.
    Drolet RE; Cannon JR; Montero L; Greenamyre JT
    Neurobiol Dis; 2009 Oct; 36(1):96-102. PubMed ID: 19595768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.
    Greene JG; Noorian AR; Srinivasan S
    Exp Neurol; 2009 Jul; 218(1):154-61. PubMed ID: 19409896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
    Naughton C; O'Toole D; Kirik D; Dowd E
    Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons.
    Bu J; Qiao X; He Y; Liu J
    Life Sci; 2019 Aug; 231():116581. PubMed ID: 31220524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.
    Sharrad DF; Chen BN; Gai WP; Vaikath N; El-Agnaf OM; Brookes SJ
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27997067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.
    Cersosimo MG; Benarroch EE
    Neurobiol Dis; 2012 Jun; 46(3):559-64. PubMed ID: 22048068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.
    Johnson ME; Stringer A; Bobrovskaya L
    Neurotoxicology; 2018 Mar; 65():174-185. PubMed ID: 29471018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
    Pellegrini C; Antonioli L; Colucci R; Ballabeni V; Barocelli E; Bernardini N; Blandizzi C; Fornai M
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1407-14. PubMed ID: 26499757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.
    Annerino DM; Arshad S; Taylor GM; Adler CH; Beach TG; Greene JG
    Acta Neuropathol; 2012 Nov; 124(5):665-80. PubMed ID: 22941241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
    Liu Y; Sun JD; Song LK; Li J; Chu SF; Yuan YH; Chen NH
    Behav Brain Res; 2015 Nov; 294():149-61. PubMed ID: 26239001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V; Cannon JR; Greenamyre JT
    J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
    Manfredsson FP; Luk KC; Benskey MJ; Gezer A; Garcia J; Kuhn NC; Sandoval IM; Patterson JR; O'Mara A; Yonkers R; Kordower JH
    Neurobiol Dis; 2018 Apr; 112():106-118. PubMed ID: 29341898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Neuroscience; 2012 Feb; 203():170-9. PubMed ID: 22198020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
    Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
    Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
    Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
    Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral administration of rotenone on gastrointestinal functions in mice.
    Tasselli M; Chaumette T; Paillusson S; Monnet Y; Lafoux A; Huchet-Cadiou C; Aubert P; Hunot S; Derkinderen P; Neunlist M
    Neurogastroenterol Motil; 2013 Mar; 25(3):e183-93. PubMed ID: 23281940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
    Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
    Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.